B-30. Immunopharmacology I (cytotoxic agents, retinoids). Pharmacotherapy of autoimmune diseases. Flashcards
Cytotoxic Agents (6)
- ) Cyclophosphamide
- ) Methotrexate
- ) Lefluomide and Teriflunomide
- ) Azathioprine
- ) Mycophenolate Mofetil
When is immunosuppressive therapy used?
- ) Autoimmune disease
- ) Blocking transplant rejection
- ) Preventing GVHD in marrow transplant
How many different antigen receptors are there?
10^12, this makes it difficult to block certain antibodies/TCRs
Mechanism of action for immunosuppression?
- ) Lymphopheresis
- Removal of lymphocytes from circulation by physical methods - ) Cytotoxic agents
- To reduce lymphocyte count - ) IL-2 inhibition
- IL-2 is a lymphocyte growth factor; can either inhibit its expression or its proliferative effect - ) Cytokine inhibition
- Via biologics including mAbs or soluble receptors - ) Migration inhibition
- Decreased movement of WBCs into tissues
Cyclophosphamide MOA
Prodrug activated by CYP450 that forms phosphoramide mustard (active metabolite) and acrolein (inactive, toxic metabolite).
These metabolites alkylate the DNA (N7 of guanosine) causing cross linking inside and between DNA chains. This alkylation results in T and B cell inhibition.
Cyclophosphamide indications
- ) SLE
- ) Systemic sclerosis
- ) Vasculitis and AI hemolytic anemia
- ) Kidney disease (AI glomerulonephritis and nephrotic syndrome)
Cyclophosphamide side effects
- ) Myelosuppression (check complete blood count during treatment)
- ) Gonadal dysfunction
- Oligospermia and ovarian issues; with increased dose over long period becomes irreversible - ) Hemorrhagic cystitis
- Due to toxic acrolein metabolite; prevent with hydration and mesna treatment - ) Teratogen/Mutagen (CI in pregnancy)
- ) GI symptoms including increased risk of bladder cancer, hyponatremia via SIADH
Methotrexate (MTX) MOA
Acts as an antimetabolite to inhibit DHF reductase decreasing dTMP and DNA synthesis.
Also has anti-inflammatory effects via MTX-polyglutamates which inhibit AICAR transformylase (purine metabolism)
*MTX-polyglutamates persit in cell longer than MTX itself
Methotrexate Admin
given orally once a week; sometimes s.c. (onset takes weeks; start with steroid/NSAIDs)
Methotrexate Indication
- ) Rheumatoid arthritis (Drug of choice in moderate/severe RA)
- ) Psoriasis (other immune-related dermatological diseases including vasculitis, etc.)
- ) SLE
- ) IBD
- ) Vasculitis
- ) Dermatomyositis
Methotrexate side effects
- ) Myelosuppression
- with megaloblastic anemia; reversible with leucovorin (folinic acid) - ) Hepatotoxic
- Increased liver enzymes; also reversible with leucovorin (day after MTX admin.) - ) Pulmonary fibrosis
- restrictive leading to decreased lung volume, FEV1 and FVC, and diffusion - ) GI issues
- Including mucositis/stomatitis (with oral ulcers) and diarrhea - ) Teratogenic (via folate deficiency)
- ) Rarely nephrotoxic
Leflunomide and Teriflunomide MOA
Reversibly inhibit dihydro-orotate dehydrogenase which inhibits pyrimidine synthesis leading to decreased T-cell proliferation and decreased antibody production by B cells
Leflunomide and Teriflunomide Indication
- ) RA (leflunomide is as effective as MTX)
- ) Remitting-relapsing MS (teriflunomide used which is an active metabolite of leflunomide)
- ) Psoriatic Arthritis
Leflunomide and Teriflunomide Administration
Leflunomide given orally with loading dose (half a week to 2 weeks)
Side effects of Leflunomide and Teriflunomide
- ) Liver dysfunction (can be severe)
- ) Exanthems (widespread rash)
- ) Alopecia
- ) Mild hypertension and diarrhea
Azathioprine (AZA) MOA
Prodrug of 6-mercaptopurine forms thio-IMP which blocks AMP/GMP (purine) synthesis
- Some of the formed thio-GTP acts as false nucleotide and halts DNA synthesis
- Results in decreased lymphocyte proliferation and increased apoptosis of lymphocytes/monocytes
Indications for Azathioprine
- ) Transplantation (decreases organ rejection)
- ) IBD (Crohn’s)
- ) SLE
- ) RA (less effective than MTX for RA; mostly for refractory cases)
- ) Vasculitis and glomerulonephritis
Azathrioprine side effects
- ) Myelosuppression with pancytopenia
- ) Hepatoxiticity and pancreatitis (monitor LFTs)
- ) Rarely, heaptic veno-occlusive disease
Interaction of of Azathioprine
6-MP is broken down by xanthine oxidase which is blocked by allopurinol leading to azathrioprine toxicity
Mycophenolate mofetil (MMF) MOA? Where is it isolated from?
Reversibly inhibits IMP dehydrogenase decreasing GMP (purine) synthesis
Lymphocytes don’t use purine “salvage” pathway, only de novo synthesis so decreased lymphocytes
Indications for Mycophenolate mofetil?
- ) Transplantation (Drug of choice for heart, liver, and kidney)
- ) Off-label uses: GVHD, SLE, nephritis, myasthenia gravis, psoriasis, RA
Mycophenolate mofetil side effects
- ) myelosupression
- Pancytopenia (specifically associated with invasive CMV infection) - ) Hypertension
- ) Hyperglycemia
- ) GI symptoms (very common with MMF; nausea, diarrhea, cramps)
Retinoid drugs (3)
- ) Isotretinoin
- ) Tazarotene
- ) Acitretin
Isotretinoin also called?
MOA?
13-cis-retinoic acid
Isotretinoin binds retinoic acid (RAR) and retinoid X (RXR) nuclear receptors and may induce apoptosis in certain cells including the sebaceous glands
Indication for Isotretinoin
Severe acne
Side effects of isotretinoin?
- ) Teratogenic
- Cleft palate, cardiac issues, etc.
- in US, requires negative pregnancy test and 2 forms of contraception before prescription - ) Vitamin A toxicity
- Nausea, vomit, vertigo, blurred vision (acute); alopecia, dry skin, hepatotoxicity, arthralgia, and pseudotumor cerebri (chronic) - ) Myelosuppresion
- Mostly anemia/thrombocytopenia, sometimes neutropenia
Acitretin MOA and indication
MOA: also an RAR/RXR agonist; inhibits cell proliferation and differentiation
Indicated in severe psoriasis
Acitretin side effects
- ) Dry mucosa and eyes
- ) Skin problems
- itching, hair loss, exfoliation, dermatitis, pyogenic granuloma - ) Teratogenic
- avoid pregnancy during and 3 years after treatment
Tazarotene use?
Locally applied retinoid cream for psoriasis
Tretinoin other name? Used for? In combo with?
All trans retinoic acid used for actue promyelocytic leukemia
Often in combo with arsenic trioxide (inducing cancer cell apoptosis)
Antimalarial drugs that are also used in autoimmune diseases (2)
Chloroquine and Hydroxychloroquine
MOA of chloroquine and hydroxychloroquine
Possibly via increased pH in macrophage lysosomes decreasing antigen catabolism and presentation
-Also block autophagy and proinflammatory mediator synthesis
Kinetics of chloroquine and hydroxychloroquine
- Well absorbed and large Vd due to high tissue binding
- Long half life (40 days); liver metabolism
Indication of chloroquine and hydroxychloroquine
- ) SLE + discoid lupus (first choice for less complicated cases)
- ) RA- monotherapy in mild cases; combo with other DMARDs (Disease-modifying antirheumatic drugs) is severe)
- ) Sjogren’s syndrome
Side effects of chloroquine and hydroxychloroquine
- ) Exanthems and pruritus (especially in dark-skinned patients)
- ) Myopathy
- ) Vision issues
- macular degeneration and corneal discoloration (require ophthalmological control) - ) Nightmares, nausea, vomiting